4 assets in Choriocarcinoma Of Testis

Therapeutic assets addressing Choriocarcinoma Of Testis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Choriocarcinoma Of Testis	Children's Oncology Group	P3	BB (66)
Bleomycin Choriocarcinoma Of Testis	Children's Oncology Group	P3	B (60)
Cis-Diamminedichloroplatinum Ii Choriocarcinoma Of Testis	Children's Oncology Group	P3	B (60)
Etoposide Choriocarcinoma Of Testis	Children's Oncology Group	P3	B (60)